NO173938C - Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrido-pyridazinon-eddiksyrer - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrido-pyridazinon-eddiksyrer

Info

Publication number
NO173938C
NO173938C NO902070A NO902070A NO173938C NO 173938 C NO173938 C NO 173938C NO 902070 A NO902070 A NO 902070A NO 902070 A NO902070 A NO 902070A NO 173938 C NO173938 C NO 173938C
Authority
NO
Norway
Prior art keywords
compounds
pyrido
preparation
therapeutically active
acetic acids
Prior art date
Application number
NO902070A
Other languages
English (en)
Norwegian (no)
Other versions
NO902070D0 (no
NO902070L (no
NO173938B (no
Inventor
Banavara Lakshmana Mylari
William James Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO902070D0 publication Critical patent/NO902070D0/no
Publication of NO902070L publication Critical patent/NO902070L/no
Publication of NO173938B publication Critical patent/NO173938B/no
Publication of NO173938C publication Critical patent/NO173938C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO902070A 1989-05-11 1990-05-10 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrido-pyridazinon-eddiksyrer NO173938C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/350,417 US4996204A (en) 1989-05-11 1989-05-11 Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors

Publications (4)

Publication Number Publication Date
NO902070D0 NO902070D0 (no) 1990-05-10
NO902070L NO902070L (no) 1990-11-12
NO173938B NO173938B (no) 1993-11-15
NO173938C true NO173938C (no) 1994-02-23

Family

ID=23376622

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902070A NO173938C (no) 1989-05-11 1990-05-10 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrido-pyridazinon-eddiksyrer

Country Status (18)

Country Link
US (1) US4996204A (fr)
EP (1) EP0401981B1 (fr)
JP (1) JPH0631235B2 (fr)
KR (1) KR920003559B1 (fr)
AT (1) ATE121743T1 (fr)
AU (1) AU611610B2 (fr)
CA (1) CA2016326C (fr)
DE (1) DE69018876T2 (fr)
DK (1) DK0401981T3 (fr)
ES (1) ES2071016T3 (fr)
FI (1) FI93013C (fr)
HU (1) HU206714B (fr)
IE (1) IE66029B1 (fr)
IL (1) IL94302A (fr)
NO (1) NO173938C (fr)
NZ (1) NZ233599A (fr)
PT (1) PT93984B (fr)
ZA (1) ZA903564B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
US5716954A (en) * 1991-10-09 1998-02-10 Syntex U.S.A. Inc. Benzopyridazinone and pyridopyridazinone compounds
US5728704A (en) * 1992-09-28 1998-03-17 Pfizer Inc. Substituted pyridmidines for control of diabetic complications
GB9314412D0 (en) * 1993-07-13 1993-08-25 Rhone Poulenc Agriculture New compositions of matter
US6214991B1 (en) 1998-03-31 2001-04-10 The Institute For Pharmaceutical Discovery, Inc. Substituted indolealkanoic acids
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
WO2002043763A2 (fr) * 2000-11-30 2002-06-06 Pfizer Products Inc. Combinaison de gaba-agonistes et d'inhibiteurs d'aldose-réductase
ATE297902T1 (de) 2001-02-28 2005-07-15 Pfizer Prod Inc Sulfonyl-pyridazinon-derivate zur verwendung als aldose-reduktase-inhibitoren
EP1491541B1 (fr) 2001-03-30 2007-01-24 Pfizer Products Inc. Pyridazinones, inhibiteurs d'aldose reductase.
CA2445871A1 (fr) * 2001-04-30 2002-11-07 Pfizer Products Inc. Combinaisons d'inhibiteurs d'aldose reductase et inhibiteurs de cyclo-oxygenase 2
AU761191B2 (en) 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia
US7572910B2 (en) * 2003-02-20 2009-08-11 Pfizer, Inc. Pyridazinone aldose reductase inhibitors
HRP20221430T1 (hr) * 2010-07-16 2023-01-06 The Trustees Of Columbia University In The City Of New York Inhibitori aldozoreduktaze i njihova uporaba
US8916563B2 (en) * 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
RS61239B1 (sr) 2016-06-21 2021-01-29 Univ Columbia Inhibitori aldozne reduktaze i postupci korišćenja
IL272246B2 (en) 2017-07-28 2026-01-01 Applied Therapeutics Inc History of 2-(4-oxo/thioketone/azo-3-((substituted)benzo[d]thiazol-2-yl)methyl)- 3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid for use as an aldose reductase inhibitor for the treatment of galactosemia or prevention of galactosemia-related complications
CA3132136A1 (fr) 2019-04-01 2020-10-08 Andrew Wasmuth Inhibiteurs de l'aldose reductase
JP2022531466A (ja) 2019-05-07 2022-07-06 ユニバーシティ オブ マイアミ 遺伝性ニューロパチーおよび関連障害の処置および検出

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE2708187A1 (de) * 1977-02-25 1978-08-31 Thomae Gmbh Dr K Neue pyrido-pyridazin-one
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4209527A (en) * 1979-05-16 1980-06-24 Pfizer Inc. Benzimidazolone derivatives
CA1160518A (fr) * 1979-07-06 1984-01-17 E. I. Du Pont De Nemours And Company Ustensiles de cuisson a revetement de ptfe
DE3684410D1 (de) * 1985-11-07 1992-04-23 Pfizer Heterocyclische oxophthalazinylessigsaeure.
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof

Also Published As

Publication number Publication date
CA2016326C (fr) 1995-05-30
DE69018876D1 (de) 1995-06-01
HU902996D0 (en) 1990-09-28
EP0401981B1 (fr) 1995-04-26
AU611610B2 (en) 1991-06-13
NO902070D0 (no) 1990-05-10
KR900018092A (ko) 1990-12-20
ZA903564B (en) 1992-08-26
HUT54683A (en) 1991-03-28
JPH035481A (ja) 1991-01-11
DK0401981T3 (da) 1995-09-04
NO902070L (no) 1990-11-12
NZ233599A (en) 1991-07-26
FI93013B (fi) 1994-10-31
JPH0631235B2 (ja) 1994-04-27
IE66029B1 (en) 1995-11-29
NO173938B (no) 1993-11-15
ES2071016T3 (es) 1995-06-16
DE69018876T2 (de) 1995-08-24
PT93984A (pt) 1991-01-08
IE901701L (en) 1990-11-11
EP0401981A1 (fr) 1990-12-12
IL94302A (en) 1994-01-25
AU5490590A (en) 1990-11-15
ATE121743T1 (de) 1995-05-15
IL94302A0 (en) 1991-03-10
CA2016326A1 (fr) 1990-11-11
FI902335A0 (fi) 1990-05-10
KR920003559B1 (ko) 1992-05-04
FI93013C (fi) 1995-02-10
HU206714B (en) 1992-12-28
US4996204A (en) 1991-02-26
PT93984B (pt) 1996-11-29

Similar Documents

Publication Publication Date Title
NO173938C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrido-pyridazinon-eddiksyrer
PT85294A (en) Indolinone derivatives
KR900018034A (ko) 치환 4-(퀴놀린-2-일-메톡시)페닐-아세트산 유도체
DE3071230D1 (en) Substituted 6-phenethyl-and phenylethenyl-3,4,5,6-tetrahydro-4-hydroxytetraydropyran-2-ones in the4-r trans stereoisomeric forms and the corresponding dihydroxy acids, process for preparing and pharmaceutical composition comprising them
IE801005L (en) Benzimidazolones.
NO177495C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive glyserinderivater
AU3077289A (en) Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
FI901994A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten aminosubstituoitujen silta-atsabisyklisten kinolonikarboksyylihappojen ja -estereiden valmistamiseksi
JPS6429363A (en) Heterocyclic derivative